FindTrial
Sign In

To study any undesired effects of 2 solutions (Minoxidil 5%) after application in male participants.

To evaluate the in-use tolerance of 2 topical solutions (Minoxidil 5 %), in men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015347
Enrollment
80
Registered
2018-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Minoxidil topical solution USP 5% w/v (Mintop AF): 1 ml of the product will be applied on areas where the hair is thin/balding areas. Twice a day application for a duration of 30 days C

Sponsors

Dr Reddys Laboratories Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Balding men based on the Norwood Hamilton Scale. Accepting not to use products with the same end benefit during the entire study duration

Exclusion criteria

Exclusion criteria: Scarring of the scalp or any other condition or disease of the scalp or hair. Participants with any cardiac abnormalities or ailments or abnormal blood pressure. Known sensitivity to the investigational product.

Design outcomes

Primary

MeasureTime frame
Clinical assessment (Redness and Scaling on scalp using a 5-point scale) Instrumental assessment(Hydration using MMSC) Subjective Self-assessmentTimepoint: Day 0 Day 15 Day 30—

Secondary

MeasureTime frame
NoneTimepoint: None—

Countries

India

Contacts

Public ContactDr Shivani Acharya

Dr. Reddys Laboratories Ltd.

shivaniacharya@drreddys.com07995015179

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026